Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mitochondrial retrograde signal through GCN5L1 transition–mediated PPARγ stabilization promotes MASLD development
Jiaqi Zhang, Danni Wang, Qiqi Tang, Yaoshu Yue, Xin Lu, Xiuya Hu, Yitong Han, Jiarun Chen, Zihan Wang, Xue Bai, Kai Zhang, Yongsheng Chang, Longhao Sun, Lu Zhu, Lingdi Wang
Jiaqi Zhang, Danni Wang, Qiqi Tang, Yaoshu Yue, Xin Lu, Xiuya Hu, Yitong Han, Jiarun Chen, Zihan Wang, Xue Bai, Kai Zhang, Yongsheng Chang, Longhao Sun, Lu Zhu, Lingdi Wang
View: Text | PDF
Research Article Cell biology Hepatology

Mitochondrial retrograde signal through GCN5L1 transition–mediated PPARγ stabilization promotes MASLD development

  • Text
  • PDF
Abstract

Mitochondrial retrograde signaling plays crucial roles in maintaining metabolic homeostasis via regulating genome modification and oxidative responsive gene expression. In this study, we identified GCN5L1, a protein localized in both mitochondria and cytoplasm, and demonstrated its specific translocation from mitochondria to cytoplasm during lipid overload and high-fat diet feeding. Using transcriptome and proteome analyses, we identified that cytoplasmic GCN5L1 binds to and promotes the acetylation of PPARγ at lysine 289 (K289). This acetylation protected PPARγ from ubiquitination-mediated degradation by proteasome. GCN5L1 translocation enhanced protein stability of PPARγ and subsequently promoted lipid accumulation in both cultured cells and murine models. Our study further reveals that PPARγ-K289 mutation reduces the ubiquitination of PPARγ and exacerbates liver steatosis in mice. These findings unveil a mitochondrial retrograde signaling during lipid overload, which regulates the crucial lipogenic transcriptional factor. This discovery elucidates an unrecognized mitochondrial function and mechanism underlying hepatic lipid synthesis.

Authors

Jiaqi Zhang, Danni Wang, Qiqi Tang, Yaoshu Yue, Xin Lu, Xiuya Hu, Yitong Han, Jiarun Chen, Zihan Wang, Xue Bai, Kai Zhang, Yongsheng Chang, Longhao Sun, Lu Zhu, Lingdi Wang

×

Figure 2

GCN5L1 deletion protects mice from HFD-induced liver steatosis but not liver injury.

Options: View larger image (or click on image) Download as PowerPoint
GCN5L1 deletion protects mice from HFD-induced liver steatosis but not l...
(A) Body weight gain of GCN5L1fl/fl (CON) and GCN5L1fl/fl-Alb-Cre (LKO) mice on NC or HFD diets for 16 weeks. n = 10, NC; n = 9, CON with HFD; n = 10, LKO with HFD. (B) Body weights of CON or LKO mice on NC or HFD for 16 weeks. n = 10, NC; n = 9, HFD. (C) Liver/body weight ratio of CON or LKO mice on NC or HFD for 16 weeks. n = 10, NC; n = 9, HFD. (D) Liver TG contents of CON or LKO mice on NC or HFD for 16 weeks. n = 10, NC; n = 9, HFD. (E) Representative images of H&E staining of livers from CON or LKO mice on HFD for 16 weeks. Scale bars: 50 μm; n = 8 mice/group. (F) Representative images of Oil Red O staining of CON or LKO mice on HFD for 16 weeks. Scale bars: 50 μm; n = 8 mice/group. (G) Representative Western blot analysis of GCN5L1-myc in WCL, Mito, and Cyto fractions of liver samples from GCN5L1-LKO mice with AAV-eGFP or AAV-GCN5L1-myc expression. (H–J) GCN5L1 CON or LKO mice were injected with AAV-eGFP or AAV-GCN5L1-myc, followed by HFD feeding for 16 weeks. Body weight (H), liver/body weight ratio (I), and liver TG contents (J) were determined (n = 6, CON with AAV-eGFP; n = 6, LKO with AAV-eGFP; n = 8, LKO with AAV-GCN5L1-myc). (K) Representative images of H&E staining (top) or Oil Red O staining (bottom) of liver sections from CON-eGFP, LKO-eGFP, or LKO-GCN5L1-myc mice on HFD for 16 weeks. Scale bars: 50 μm; n = 6 mice/group. Data in A–D were derived from a single cohort of mice. Data in H–J pertain to an independent cohort of mice. Datasets in A were analyzed by 2-factor repeated-measures ANOVA with Bonferroni correction; in B and H–K were analyzed by 1-way ANOVA with Bonferroni correction; in C and D were analyzed by Welch’s ANOVA with Games-Howell post hoc tests; in E and F were analyzed by 2-tailed Student’s t test. ns, P > 0.05; *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts